SYNVISC-ONE (Hylan G-F 20) - Synovial fluid supplementation substance

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Disponible desde:

Sanofi-Aventis Australia Pty Ltd

clase:

Class III

Fabricado por:

Genzyme Corporation 1125 Pleasant View Terrace, Ridgefield, NJ, 07657 United States Of America

Área terapéutica:

44757 - Synovial fluid supplementation substance

indicaciones terapéuticas:

A sterile, nonpyrogenic, elastoviscous fluid containing hylan polycaccharide (Hylan polymer 8.0 mg/mL) hydrated in physiological saline. Synvisc-One is only intended for intra-articular use to treat pain associated with osteoarthritis of the knee.

Estado de Autorización:

A

Fecha de autorización:

2009-02-09